Clinical Topics Endocrinology News Patient Safety Workplace Management

Study reveals connection between use of proton pump inhibitors and risk of type 2 diabetes

Share

October 14, 2020

By: Lydia L. Kim, Digital Content Editor

A study published in BMJ Gut examined “the association between the regular use of proton pump inhibitors (PPI) and the risk of type 2 diabetes.”

The study followed over 200,000 participants who did not have diabetes prior to the follow-up study. During the follow up, the researchers confirmed over 10,000 cases of diabetes. Additionally, they found that the regular PPI users had a “24% higher risk of diabetes than non-users.”

Though more research is needed in this area, these types of results may indicate a need for healthcare professionals to education their patients on PPI and “exercise caution when prescribing PPIs.”

Click here to read the full study.

Source:
https://gut.bmj.com/content/early/2020/08/29/gutjnl-2020-322557.full

The views and opinions expressed here are those of the author and do not necessarily reflect the opinions or recommendations of the American Nurses Association, the Editorial Advisory Board members, or the Publisher, Editors and staff of American Nurse Journal. This has not been peer reviewed.